Dorzolamide Hydrochloride
Who holds supplier records for Dorzolamide Hydrochloride? 12 organisations hold a current record for Dorzolamide Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), Spain (1), Italy (1), Netherlands (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dorzolamide Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dorzolamide-hydrochloride
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
7 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dorzolamide Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CURIA SPAIN SAUSpainCEP Company GMP cert on recordActive DMF 18385 · latest filing May 2005
- FIS FABBRICA ITALIANA SINTETICI SPAItalyCEP Company GMP cert on recordActive DMF 20740, 29584 · latest filing Jul 2015
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 26204, 21910 · latest filing Jul 2012
- INDOCO REMEDIES LTDIndiaCEP Company GMP cert on recordActive DMF 23795 · latest filing May 2010
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 24753 · latest filing Feb 2011
- Neuland Laboratories LimitedIndiaCEPActive DMF 33024 · latest filing Nov 2018
- SHOBHA LIFE SCIENCES PRIVATE LIMITEDIndiaCEPActive DMF 41644 · latest filing Apr 2025
- TAPI NL BVNetherlandsCEPActive DMF 20441 · latest filing Apr 2007
- C-SQUARED PHARMA LTDUnited StatesActive DMF 43885 · latest filing Apr 2026
- CENTURY PHARMACEUTICALS LTDActive DMF 34797 · latest filing Jul 2020
- FDC LimitedIndiaCEP Company GMP cert on recordActive DMF 20856, 33576 · latest filing Apr 2019
- GLOBAL CALCIUM PRIVATE LTDIndia Company GMP cert on recordActive DMF 39629 · latest filing Jul 2024
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (9)
Certificates of Suitability on the EDQM register for Dorzolamide Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 15 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| FDC LIMITED Mumbai | IN | CEP 2023-236 - Rev 01 Dorzolamide hydrochloride, Process 2 | Jul 2026 | — |
| SHOBHA LIFE SCIENCES PRIVATE LIMITED Chityala | IN | CEP 2025-065 - Rev 00 Dorzolamide hydrochloride | Aug 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2009-093 - Rev 04 Dorzolamide hydrochloride | Jul 2025 | — |
| CURIA SPAIN S.A.U. Boecillo | ES | CEP 2010-115 - Rev 04 Dorzolamide hydrochloride | Jul 2025 | Inspected Feb 2026 Spain |
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2017-089 - Rev 01 Dorzolamide hydrochloride, Process II | May 2025 | — |
| MICRO LABS LIMITED Bengaluru | IN | CEP 2020-308 - Rev 02 Dorzolamide hydrochloride, Process-II | Oct 2024 | — |
| INDOCO REMEDIES LIMITED Mumbai | IN | CEP 2011-015 - Rev 01 Dorzolamide hydrochloride | Dec 2023 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2017-050 - Rev 02 Dorzolamide hydrochloride | Nov 2023 | — |
| F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore | IT | R1-CEP 2008-308 - Rev 03 Dorzolamide hydrochloride | Mar 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Dorzolamide Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- Bachem SA, Succursale de VionnazSwitzerland · Inactive DMF 23385 · filed Dec 2009
- Inactive DMF 21626 · filed May 2008
- France · Inactive DMF 21349 · filed Feb 2008
- India · Inactive DMF 20284 · filed Feb 2007
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Dorzolamide Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201162).
Chemical identity
- IUPAC name
- (4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride
- Canonical SMILES
- CCN[C@H]1C[C@@H](S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl
- InChIKey
- OSRUSFPMRGDLAG-QMGYSKNISA-N
- Synonyms
- Cosopt pf, Dorzolamide (as hydrochloride), Dorzolamide hcl, Dorzolamide hydrochloride, Dorzolamide hydrochloride component of cosopt, MK-507, Trusopt, CHEBI:4703, Dorzolamide PF, Dorzolamide HCI, RefChem:57215, Dorzolamide Hydrochloride Ophthalmic
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Carbonic Anhydrase Inhibitor
- Mechanism of action
- Carbonic Anhydrase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dorzolamide Hydrochloride?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Dorzolamide Hydrochloride: CURIA SPAIN SAU (Spain), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), Hetero Drugs Limited (India), INDOCO REMEDIES LTD (India), MICRO LABS LTD (India), Neuland Laboratories Limited (India), SHOBHA LIFE SCIENCES PRIVATE LIMITED (India) and TAPI NL BV (Netherlands), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dorzolamide Hydrochloride Drug Master Files are active?
CURIA SPAIN SAU (DMF 18385), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 20740, 29584), Hetero Drugs Limited (DMF 26204, 21910), INDOCO REMEDIES LTD (DMF 23795), MICRO LABS LTD (DMF 24753), Neuland Laboratories Limited (DMF 33024), SHOBHA LIFE SCIENCES PRIVATE LIMITED (DMF 41644) and TAPI NL BV (DMF 20441) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dorzolamide Hydrochloride records mean?
4 organisations have only inactive Type II DMFs for Dorzolamide Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Dorzolamide Hydrochloride have a European Certificate of Suitability?
Yes. 9 organisations hold a valid CEP for Dorzolamide Hydrochloride on the EDQM register, including FDC LIMITED Mumbai (IN), SHOBHA LIFE SCIENCES PRIVATE LIMITED Chityala (IN), TAPI NL B.V. Amsterdam (NL), CURIA SPAIN S.A.U. Boecillo (ES), NEULAND LABORATORIES LIMITED Hyderabad (IN) and MICRO LABS LIMITED Bengaluru (IN) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Dorzolamide Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dorzolamide Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.